Development of ¹¹¹In-labelled antibody targeting ADAM8 for early diagnosis of pancreatic cancer.

○Tsukasa Kosugi

[28P02-064S] Development of ¹¹¹In-labelled antibody targeting ADAM8 for early diagnosis of pancreatic cancer.

○Tsukasa Kosugi¹, Ryota Yamaguchi², Yusuke Tanahara², Yusuke Miyanari³, Ayako Tagawa³, Tomohiko Adachi², Sakura Yoshida², Akira Toriba², Takeshi Fuchigami² (1. Fac. Pharm. Sci., Nagasaki Univ., 2. Grad. Sch. Biomed. Sci., Nagasaki Univ., 3. WPI Nano Life Science Institute, Kanazawa Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[28P02] 放射化学

[28P02-064S] Development of ¹¹¹In-labelled antibody targeting ADAM8 for early diagnosis of pancreatic cancer.

Password